Provider willingness to screen all sexually active adolescents for chlamydia

Sexually Transmitted Infections

Volumn 78, Issue 5, 2002, Pages 369-373

  Boekeloo, Bradley O ^a   Snyder, M H ^b   Bobbin, M ^a   Burstein, G R ^c   Conley, D ^b   Quinn, T C ^c   Zenilman, J M ^c  

^a UNIVERSITY OF MARYLAND   (United States)

^b KAISER PERMANENTE   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHLAMYDIA; CHLAMYDIASIS; COST EFFECTIVENESS ANALYSIS; FEMALE; HEALTH CARE PERSONNEL; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MANAGED CARE ORGANIZATION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUESTIONNAIRE; SCREENING; SEXUAL BEHAVIOR; URINALYSIS;

ADOLESCENT; CHLAMYDIA INFECTIONS; COST-BENEFIT ANALYSIS; DELIVERY OF HEALTH CARE; FEMALE; HEALTH CARE SURVEYS; HUMANS; MALE; MANAGED CARE PROGRAMS; MASS SCREENING; MID-ATLANTIC REGION; MULTIVARIATE ANALYSIS; PRIMARY HEALTH CARE; SEXUAL BEHAVIOR;

EID: 0036799990     PISSN: 13684973     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.78.5.369     Document Type: Article

References (38)

1. Centers for Disease Control and Prevention. Sexually transmitted disease surveillance, 2000. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, September 2001.
2. US Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore: Williams and Wilkins, 1996.
3. Centers for Disease Control and Prevention. Recommendations for the prevention and management of Chlamydia trachomatis infections, 1993. MMWR Morb Mortal Wkly Rep 1993;42:1-32.
4. Elster AB, Kuznets NJ. AMA Guidelines for adalescent preventive services (GAPS) recommendations and rationale. Baltimore: Williams and Wilkins; 1994.
5. Green M, ed. Bright futures: guidelines for health supervision af infants, children, and adolescents. Arlington, VA: National Center for Education in Maternal and Child Health. 1994.
6. American Academy of Pediatrics. Recommendations for preventive pediatric health care (RE9939). Available at http://www.aap.ord/policy/RE9939.html. Accessed 7 March 2001.
7. Orr DP, Fortenberry JD. Screening adolescents for sexually transmitted infections. JAMA 1998;280:564-5.
8. Burstein GR, Gaydos CA, Diener-West M, et al. Incident Chlamydia trachomatis infections among inner city adolescent females. JAMA 1998;280:521-6.
9. Whittington WL, Kent C, Kissinger P, et al. Determinants of persistent and recurrent Chlamydia trachomatis infection in young women: results of a multicenter cohort study. Sex Transm Dis 2001;28:117-23.
10. Mangione-Smith R, O'Leary J, McGlynn EA. Health and cost-benefits of chlamydia screening in young women. Sex Transm Dis 1999;26:309-16.
11. Thrall JS, McCloskey L, Spivak H, et al. Performance of Massachusetts HMOs in providing Pap smear and sexually transmitted disease screening to adolescent females. J Adolesc Health 1998;22:184-9.
12. Torkko KC, Gershman K Crane LA, et al. Testing for chlamydia and sexual history taking in adolescent females: results from a statewide survey of Colorado primary care providers. Pediatrics 2000;106:e32 [serial online].
13. Cook RL, Wiesenfeld HC, Ashton MR, et al. Barriers to screening sexually active adolescent women for chlamydia: a survey of primary care physicians. J Adolesc Health 2001;28:204-10.
14. Rietmeijer CA, Van Bemmelen R, Judson FN, et al. Incidence and repeat infection rates of Chlamydia trachomatis among male and female patients in an STD clinic: implications for screening and rescreening Sex Transm Dis 2002;29:65-72.
15. Marrazzo JM, White CL, Krekeler B, et al. Community-based urine screening for Chlamydia trachomatis with a ligase chain reaction reaction assay. Ann Intern Med 1997;127:796-803.
16. Rietmeijer CA, Yamaguchi KJ, Ortiz CG, et al. Feasibility and yield of screening urine for Chlamydia trachomatis by polymerase chain reaction among high-risk male youth in field-based and other nonclinic settings. A new strategy for sexually transmitted disease control. Sex Transm Dis 1997;24:429-35.
17. Bull SS, Rietmeijer C, Fortenberry JD, et al. 1999 Practice patterns for the elicitation of sexual history, education, and counseling among providers of STD services: results from the gonorrhea community action project (GCAP). Sex Transm Dis 1999;26:584-9.
18. Boekeloo BO, Marx ES, Kral AH, et al. Frequency and thoroughness of STD/HIV risk assessment by physicians in a high-risk metropolitan area. Am J Public Health 1991;81:1645-8.
19. Epstein RM, Morse DS, Frankel RM, et al.Awkward moments in patient-physician communication about HIV risk. Ann Intern Med 1998;128:435-42.
20. Carney PA, Ward DH. Using unannounced standardized patients to assess the HIV preventive practices of family nurse practitioners and family physicians. Nurse Pract 1998;23:56-58, 63, 67-8.
21. Howell MR, Quinn TC, Gaydos CA. Screening for Chlamydia trachomatis in asymptomatic women attending family planning clinics. A cost-effectiveness analysis of three strategies. Ann Intern Med 1998;128:277-84.
22. Marrazzo JM, Celum CL, Hillis SD, et al. Performance and cost-effectiveness of selective screening criteria for Chlamydia trachomatis infection in women. Implications for a national chlamydia control strategy. Sex Transm Dis 1997;24:131-41.
23. Ciemins EL, Kent CK, Flood J, et al. Evaluation of chlamydia and gonorrhea screening criteria: San Francisco sexually transmitted disease clinic: 1997 to 1998. Sex Transm Dis 2000;27:165-7.
24. Shafer MA, Pantell RH, Schachter J. Is the routine pelvic examination needed with the advent of urine-based screening for sexually transmitted diseases? Arch Pediatr Adolesc Med 1999;153:111-13.
25. Holder DW, Woods ER. Chlamydia trachomatis screening in the adolescent population. Curr Opin Pediatr 1997;9:317-24.
26. SPSS for Windows. Rel. 10.0.5. Chicago: SPSS Inc, 1999.
27. Burstein GR, Snyder MH, Conley D, et al. Adolescent Chlamydia testing practices and diagnosed infections in a large managed care organization. Sex Transm Dis 2000;28:477-83.
28. Kann L, Kinchen SA, Williams BI, et al. Youth risk behavior surveillance-United States, 1999. In: CDC Surveillance Summaries, June 9, 2000. MMWR 2000;49(No SS-5):19-21.
29. Pierpoint T, Thomas B, Judd A, et al. Prevalence of Chlamydia trachomatis in young men in north west London. Sex Transm Infect 2000;76:273-6.
30. Porter LE, Ku L. Use of reproductive health services among young men, 1995. J Adolesc Health 2000;27:186-94.
31. Millstein SG, Igra V, Gans J. Delivery of STD/HIV preventive services to adolescents by primary care physicians. J Adoles Health 1996;19:249-57.
32. Stokes T, Bhaduri S, Schober P, et al. GPs' management of genital Chlamydia: a survey of reported practice. Fam Pract 1997;14:455-60.
33. Fenton KA. Screening men for Chlamydia trachomatis infection: have we fully explored the possibilities? Commun Dis Public Health 2000;3:86-9.
34. Shafer MA, Pantell RH, Schachter J. Is the routine pelvic examination needed with the advent of urine-based screening for sexually transmitted diseases? Arch Pediatr Adolesc Med 1999;153:111-13.
35. Gunn RA, Podschun GD, Fitzgerald S, et al. Screening high-risk adolescent males for Chlamydia trachomatis infection. Obtaining urine specimens in the field. Sex Transm Dis 1998;25:49-52.
36. Oh MK, Richey CM, Pate MS, et al. High prevalence of Chlamydia trachomatis infections in adolescent females not having pelvic examinations: utility of PCR-based urine screening in urban adolescent clinic setting. J Adol Health 1997;21:80-6.
37. Howell MR, Gaydos JC, McKee KT Jr, et al. Control of Chlamydia trachomatis infections in female army recruits: cost-effective screening and treatment in training cohorts to prevent pelvic inflammatory disease. Sex Transm Dis 1999;26:519-26.
38. Webb KH. Cost-effective screening for Chlamydia trachomatis: are DNA amplification assays the answer? Sex Transm Dis 1998;25:403-7.